Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)


$2.9800
-0.0200 ( -1.06% ) 2.9K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Open


$2.9800

Previous close


$3.0000

Volume


2.9K

Market cap


$202.76M

Day range


$3.0120 - $3.1750

52 week range


$2.2800 - $19.0500

SEC Filings


Form Type Description Pages Date
8-k 8K-related 49 Nov 21, 2024
8-k 8K-related 118 Nov 15, 2024
8-k 8K-related 13 Nov 12, 2024
10-q Quarterly Reports 78 Nov 12, 2024
8-k 8K-related 15 Oct 11, 2024
8-k 8K-related 16 Sep 20, 2024
8-k 8K-related 13 Sep 05, 2024
8-k 8K-related 11 Aug 30, 2024
8-k 8K-related 11 Aug 19, 2024
10-q Quarterly Reports 80 Aug 13, 2024

Latest News